A possible role of tumor necrosis factor alpha (TNFalpha) in the pathomechanism of sarcoidosis must be considered in the analysis of this disorder since elevated concentrations of this cytokine have been found. In addition, TNFalpha expression could be demonstrated in sarcoid granulomata [1]. It is well known that TNFalpha plays a crucial role in granulomatous inflammation, e.g., in mycobacterial diseases [2]. Therefore, TNFalpha blockade is a potential approach in the therapy for sarcoidosis. Up to now, various cases of therapy-resistant sarcoidosis treated with anti-TNFalpha (infliximab and etanercept) have been reported [3-8]. Here, we describe successful treatment using adalimumab, a human recombinant immunoglobulin (Ig) G1 anti-TNF monoclonal antibody [9].
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10067-005-0037-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Role of Lasers in Connective Tissue and Inflammatory Dermatoses: A 10-Year Retrospective Review of 60 Patients in a UK Tertiary Laser Clinic.
Indian Dermatol Online J
August 2023
Department of Dermatology, Laser Division, Salford Royal NHS Foundation Trust Hospital, Stott Lane, Salford, Manchester, United Kingdom.
Article Synopsis
- The study examines the effectiveness of lasers in treating inflammatory dermatoses and connective tissue disorders, noting that previous evidence on this topic is limited.
- A retrospective review of 60 cases treated at a laser clinic from 2010 to 2020 shows that 62% of patients experienced significant improvement, mainly with pulsed dye lasers, while some faced side effects like purpura.
- Despite the study's findings suggesting lasers can help manage challenging skin conditions, it acknowledges limitations due to a lack of objective measures for assessing outcomes.
Dermoscopy of a single plaque on the face: an uncommon presentation of cutaneous sarcoidosis.
Dermatol Pract Concept
July 2018
Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy.
Sarcoidosis is a multisystemic granulomatous disease of unknown causes, and cutaneous sarcoidosis (CS) is an early manifestation of the disease. Dermoscopy has gained increasing interest in the past few years as an aid in the clinical diagnosis of inflammatory and infectious skin manifestations. We present a case report about a single, erythematous, and asymptomatic plaque on the face with unexpected dermoscopy characteristics of CS.
View Article and Find Full Text PDFType-specific L1 virus-like particle-mediated protection of horses from experimental bovine papillomavirus 1-induced pseudo-sarcoid formation is long-lasting.
J Gen Virol
June 2017
Research Group Oncology, Large Animal Surgery and Orthopaedics, Equine Clinic, University of Veterinary Medicine, Vienna, Austria.
Equine sarcoids are common therapy-resistant skin tumours induced by bovine papillomavirus type 1 or 2 (BPV1, BPV2) infection. We have previously shown that prophylactic vaccination with BPV1 L1 virus-like particles (VLPs) efficiently protects horses from experimental BPV1-induced pseudo-sarcoid development. Here, we assessed BPV1 L1 VLP vaccine-mediated long-term protection from experimental tumour formation in seven horses 5 years after immunization with three different doses of BPV1 L1 VLPs, and three unvaccinated control animals.
View Article and Find Full Text PDFOvernight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practice.
Clin Neuropharmacol
June 2015
Departments of *Neurology, and †Rheumatology, Rikshospitalet, Oslo University Hospital; and ‡University of Oslo, Oslo, Norway.
Objectives: Central nervous system manifestations of sarcoidosis occur in approximately 5% of patients with sarcoidosis, often lead to substantial morbidity, and therefore require immediate treatment. Spinal cord involvement is exceptionally rare. The tumor necrosis factor-α inhibitor infliximab seems to be an effective alternative in severe cases, refractory to other therapies, but a standard concept of treatment is lacking.
View Article and Find Full Text PDFTreatment of disseminated granuloma annulare with allopurinol: case report.
Dermatol Ther
May 2010
Department of Dermatology, Lucca, Italy.
Granuloma annulare (GA) is a rare disease characterized by granulomatous inflammation of the dermis. A variant form of the disease, disseminated granuloma annulare (DGA), can be observed in about 15% of affected patients. Localized GA is likely to resolve spontaneously within months or a few years, whereas DGA can persist for decades.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!